Testing the SurVaxM Vaccine for Lung Cancer Prevention
Clinical trial NCT07169617 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07169617
- Sponsor
- National Cancer Institute (NCI)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2029-03-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.